- Issuer ticker
-
POAI
- Reported as of
-
01 Nov 2022
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
01 Nov 2022, 20:54:27 UTC
Filing notes and source
Key filing fact
J. Melville Engle filed Form 4 for Predictive Oncology Inc. (POAI) on 01 Nov 2022.
Key facts
- This page summarizes J. Melville Engle's Form 4 filing for Predictive Oncology Inc. (POAI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Nov 2022, 20:54.
Change
- Previous filing in this sequence was filed on 24 May 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
POAI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +213,300
- Change %
- +105%
- Price
-
$0.000000
- Shares after
- 416,693
- Date
- 01 Nov 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Section 16 status
J. Melville Engle is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
SEC remarks
Power of Attorney document filed herewith.